SIMULECT (Basiliximab)-20mg

Simulect (Basiliximab) is an immunosuppressant drug known as a monoclonal antibody. It works by slowing down your body’s defense system (immune system) to prevent your body from rejecting the new kidney after surgery (acute rejection).

When a patient receives a kidney transplant, the body’s white blood cells will try to get rid of (reject) the transplanted kidney. Basiliximab works by preventing the white blood cells from getting rid of the transplanted kidney. The effect of basiliximab on the white blood cells may also reduce the body’s ability to fight infections.

Enquiry Now
Category:

Additional information

Trade Name

SIMULECT

Generic Name

Basiliximab

Manufacturer

Novartis India Ltd

Indication

Immunosuppresant

Doasage Form

Injectible

Packaging

1 x 5ml -20mg